Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine R Degnin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Trends in Endocrinology and Metabolism: TEM|September 1, 2009
FGFs in endochondral skeletal developmentWilliam A Horton, Catherine R Degnin
Molecular Biology of the Cell|August 26, 2011
Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3Catherine R Degnin, Melanie B Laederich, William A Horton
Journal of Cellular Biochemistry|June 22, 2010
FGFs in endochondral skeletal developmentCatherine R Degnin, Melanie B Laederich, William A Horton
The Journal of Biological Chemistry|April 14, 2011
Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: implications for therapeutic manipulationMelanie B Laederich, Catherine R Degnin, Gregory P Lunstrum, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|February 22, 2011
Novel type II collagen reporter mice: New tool for assessing collagen 2α1 expression in vivo and in vitroMarianna A Tryfonidou, Gregory P Lunstrum, Kristyanne Hendriks, et al.
Cellular Signalling|May 20, 2008
Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasiaChangsheng Guo, Catherine R Degnin, Melanie B Laederich, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Preferential use of imaging modalities in staging newly diagnosed rectal cancer: a survey of US radiation oncologistsJehan Belal Yahya, Matthew Joseph Farrell, Daniel O Herzig, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Does a fine line exist between regional and metastatic pelvic lymph nodes in rectal cancer-striking discordance between national guidelines and treatment recommendations by US radiation oncologistsJehan Belal Yahya, Daniel O Herzig, Matthew Joseph Farrell, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic ImpairmentNima Nabavizadeh, Joseph G Waller, Robert Fain, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Trends in Endocrinology and Metabolism: TEM|September 1, 2009
FGFs in endochondral skeletal developmentWilliam A Horton, Catherine R Degnin
Molecular Biology of the Cell|August 26, 2011
Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3Catherine R Degnin, Melanie B Laederich, William A Horton
Journal of Cellular Biochemistry|June 22, 2010
FGFs in endochondral skeletal developmentCatherine R Degnin, Melanie B Laederich, William A Horton
The Journal of Biological Chemistry|April 14, 2011
Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: implications for therapeutic manipulationMelanie B Laederich, Catherine R Degnin, Gregory P Lunstrum, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|February 22, 2011
Novel type II collagen reporter mice: New tool for assessing collagen 2α1 expression in vivo and in vitroMarianna A Tryfonidou, Gregory P Lunstrum, Kristyanne Hendriks, et al.
Cellular Signalling|May 20, 2008
Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasiaChangsheng Guo, Catherine R Degnin, Melanie B Laederich, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Preferential use of imaging modalities in staging newly diagnosed rectal cancer: a survey of US radiation oncologistsJehan Belal Yahya, Matthew Joseph Farrell, Daniel O Herzig, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Does a fine line exist between regional and metastatic pelvic lymph nodes in rectal cancer-striking discordance between national guidelines and treatment recommendations by US radiation oncologistsJehan Belal Yahya, Daniel O Herzig, Matthew Joseph Farrell, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic ImpairmentNima Nabavizadeh, Joseph G Waller, Robert Fain, et al.
Pageof 1